ATLAS / Macro Radar / Reporting / TRDA

Entrada Therapeutics, Inc. (TRDA) reporting calendar

Entrada Therapeutics, Inc. files periodic reports with the SEC as TRDA on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 17 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open TRDA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001689375-26-000028
10-K31 Dec 202526 Feb 202657 days0001689375-26-000011
10-Q30 Sep 20256 Nov 202537 days0001689375-25-000050
10-Q30 Jun 20256 Aug 202537 days0001689375-25-000043
10-Q31 Mar 20258 May 202538 days0001689375-25-000024
10-K31 Dec 202427 Feb 202558 days0001689375-25-000011
10-Q30 Sep 20245 Nov 202436 days0001689375-24-000063
10-Q30 Jun 202413 Aug 202444 days0001689375-24-000047
10-Q31 Mar 20247 May 202437 days0001689375-24-000027
10-K31 Dec 202313 Mar 202473 days0001689375-24-000016
10-Q30 Sep 20237 Nov 202338 days0001689375-23-000074
10-Q30 Jun 20238 Aug 202339 days0001689375-23-000055
10-Q31 Mar 202310 May 202340 days0001689375-23-000039
10-K31 Dec 20226 Mar 202365 days0001689375-23-000019
10-Q30 Sep 20227 Nov 202238 days0001689375-22-000045
10-Q30 Jun 202211 Aug 202242 days0001689375-22-000013
10-Q31 Mar 202212 May 202242 days0001689375-22-000004
10-K31 Dec 202115 Mar 202274 days0001558370-22-003614
10-Q30 Sep 20219 Dec 202170 days0001558370-21-016637

Source: SEC EDGAR company submissions for CIK 0001689375. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.